What does PHARMACIE DU PERRON do?

PHARMACIE DU PERRON is a logistics company in Andenne. Private Limited, started on 11 December 1989, 1 establishment.

What is the address of PHARMACIE DU PERRON?

The registered office of PHARMACIE DU PERRON is located at Rue Léon Simon 20, 5300 Andenne.

Is PHARMACIE DU PERRON still active?

Yes. According to the CBE (31 October 2026) PHARMACIE DU PERRON is active, legal situation “Normale toestand”, started on 11 December 1989.

Is PHARMACIE DU PERRON registered on Peppol?

Yes, PHARMACIE DU PERRON is registered on the Peppol network with ID 0208:0439199568.

What is the enterprise number of PHARMACIE DU PERRON?

The enterprise number of PHARMACIE DU PERRON is BE0439199568.

When was PHARMACIE DU PERRON founded?

PHARMACIE DU PERRON was founded on 11 December 1989.

Who are the directors of PHARMACIE DU PERRON?

According to the 2025 annual accounts, the directors of PHARMACIE DU PERRON are: AD PHARMA SRL.

Is PHARMACIE DU PERRON a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 December 1989; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DU PERRON make in 2025?

PHARMACIE DU PERRON posted a profit after taxes of € 82,576 in financial year 2025.

What is the revenue of PHARMACIE DU PERRON?

As a small company, PHARMACIE DU PERRON is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 231,763.

How much does an employee at PHARMACIE DU PERRON earn?

The average wage cost per full-time employee at PHARMACIE DU PERRON was € 61,400 in 2025: staff costs of € 98,226 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DU PERRON have?

According to the 2025 annual accounts, PHARMACIE DU PERRON has 1.6 full-time equivalents (FTE).

PHARMACIE DU PERRON (Private Limited) - Andenne

Dossier PHARMACIE DU PERRON, printed on 1 November 2026 from databakkes.be/en/0439199568/pharmacie-du-perron. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DU PERRON from Andenne, company number BE0439199568, closed financial year 2025 with a result of € 82,576 after tax. For that financial year PHARMACIE DU PERRON recorded a gross margin of € 231,763 and equity of € 176,116. Compared with financial year 2024, the result moved from € -11,555 to € 82,576. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 176,116

▲ 88% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 82,576

▲ still € 11,555 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 163,749

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 114,116.

People and assets in 2025

Full-time equivalents

1.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 98,226

▲ 7% vs 2024

€ 61,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 141,601

▲ 60% vs 2024

€ 27,406 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 207,486

▲ 36% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 11,729

▲ 139% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 118,588 Gross margin 2022: € 118,588 First fiscal year in the series	€ 130,088 Gross margin 2023: € 130,088 ▲ 10% vs 2022 (€ 118,588) Favourable step	€ 107,670 Gross margin 2024: € 107,670 ▼ 17% vs 2023 (€ 130,088) Unfavourable step	€ 231,763 Gross margin 2025: € 231,763 ▲ 115% vs 2024 (€ 107,670) Favourable step	▲ 115%
Profit after taxes	€ 4,784 Profit after taxes 2022: € 4,784 First fiscal year in the series	€ -2,903 Profit after taxes 2023: € -2,903 ▼ € 7,687 vs 2022 (€ 4,784) Unfavourable step	€ -11,555 Profit after taxes 2024: € -11,555 ▼ € 8,652 vs 2023 (€ -2,903) Unfavourable step	€ 82,576 Profit after taxes 2025: € 82,576 ▲ € 94,131 vs 2024 (€ -11,555) Favourable step	▲ € 94,131
Equity	€ 107,997 Equity 2022: € 107,997 First fiscal year in the series	€ 105,094 Equity 2023: € 105,094 ▼ 3% vs 2022 (€ 107,997) Unfavourable step	€ 93,539 Equity 2024: € 93,539 ▼ 11% vs 2023 (€ 105,094) Unfavourable step	€ 176,116 Equity 2025: € 176,116 ▲ 88% vs 2024 (€ 93,539) Favourable step	▲ 88%
Total debts	€ 431,432 Total debts 2022: € 431,432 First fiscal year in the series	€ 417,766 Total debts 2023: € 417,766 ▼ 3% vs 2022 (€ 431,432) Favourable step	€ 429,828 Total debts 2024: € 429,828 ▲ 3% vs 2023 (€ 417,766) Unfavourable step	€ 428,080 Total debts 2025: € 428,080 Unchanged (€ 429,828) Favourable step
Cash	€ 91,364 Cash 2022: € 91,364 First fiscal year in the series	€ 101,480 Cash 2023: € 101,480 ▲ 11% vs 2022 (€ 91,364) Favourable step	€ 121,737 Cash 2024: € 121,737 ▲ 20% vs 2023 (€ 101,480) Favourable step	€ 163,749 Cash 2025: € 163,749 ▲ 35% vs 2024 (€ 121,737) Favourable step	▲ 35%
Land & buildings	€ 170,625 Land & buildings 2022: € 170,625 First fiscal year in the series	€ 164,846 Land & buildings 2023: € 164,846 ▼ 3% vs 2022 (€ 170,625) Unchanged	€ 159,067 Land & buildings 2024: € 159,067 ▼ 4% vs 2023 (€ 164,846) Unchanged	€ 153,288 Land & buildings 2025: € 153,288 ▼ 4% vs 2024 (€ 159,067) Unchanged	▼ 4%
Retained profit	€ 45,997 Retained profit 2022: € 45,997 First fiscal year in the series	€ 43,094 Retained profit 2023: € 43,094 ▼ 6% vs 2022 (€ 45,997) Unfavourable step	€ 31,539 Retained profit 2024: € 31,539 ▼ 27% vs 2023 (€ 43,094) Unfavourable step	€ 114,116 Retained profit 2025: € 114,116 ▲ 262% vs 2024 (€ 31,539) Favourable step	▲ 262%
Bank debt	€ 139,963 Bank debt 2022: € 139,963 First fiscal year in the series	€ 114,493 Bank debt 2023: € 114,493 ▼ 18% vs 2022 (€ 139,963) Favourable step	€ 88,374 Bank debt 2024: € 88,374 ▼ 23% vs 2023 (€ 114,493) Favourable step	€ 141,601 Bank debt 2025: € 141,601 ▲ 60% vs 2024 (€ 88,374) Unfavourable step	▲ 60%
Balance sheet total	€ 539,428 Balance sheet total 2022: € 539,428 First fiscal year in the series	€ 522,860 Balance sheet total 2023: € 522,860 ▼ 3% vs 2022 (€ 539,428) Unchanged	€ 523,367 Balance sheet total 2024: € 523,367 Unchanged (€ 522,860) Unchanged	€ 604,196 Balance sheet total 2025: € 604,196 ▲ 15% vs 2024 (€ 523,367) Unchanged	▲ 15%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.6 Employees (FTE) 2023: 1.6 Unchanged (1.6) Unchanged	0 Employees (FTE) 2024: 0 ▼ 1.6 vs 2023 (1.6) Unchanged	1.6 Employees (FTE) 2025: 1.6 Unchanged (0) Unchanged

Key figures of PHARMACIE DU PERRON, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DU PERRON?

What happened at PHARMACIE DU PERRON in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 82,576. Source: NBB ↗
2025 AD PHARMA SRL became a director. NBB
Feb 6, 1990 New establishment in Andenne. KBO
Dec 11, 1989 Start of the company according to the CBE. KBO

In short

From € 4,784 profit in 2022 to € 82,576 profit in 2025.

Paid € 32,926 in corporate taxes since 2022.

Best year ever: 2025, with € 82,576 profit.

On average € 144,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

AD PHARMA 100%

ROEL FIEY MANAGEMENT 60%

DE WOLF MANAGEMENT 40%

The stake of AD PHARMA, ROEL FIEY MANAGEMENT, DE WOLF MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DU PERRON

Behind PHARMACIE DU PERRON is AD PHARMA SRL. The shares are held by AD PHARMA (100%), ROEL FIEY MANAGEMENT (60%) and DE WOLF MANAGEMENT (40%).

Directors

According to the 2025 annual accounts

AD PHARMA SRL

Director · represented by Christophe Dimitri

Also active at: PHARMACIE D'ANDENELLE

since 2025

Shareholders

AD PHARMA

100%

ROEL FIEY MANAGEMENT

60%

DE WOLF MANAGEMENT

40%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Léon Simon 20

5300 Andenne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0439.199.568

VAT number

BE 0439.199.568

Registered office

Rue Léon Simon 20, 5300 Andenne

Names & denominations

PHARMACIE DU PERRON

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 December 1989

Peppol

Active · Active since 17 Nov 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DU PERRON

Financials

What happened to PHARMACIE DU PERRON?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions